Former Affymetrix execs seek to break up Thermo Fisher deal with own bid

|By:, SA News Editor

Affymetrix (NASDAQ:AFFX) vaulted to eight-year highs in today's trade after receiving a rival bid for its proposed $1.3B sale to Thermo Fisher (NYSE:TMO).

Origin Technologies, a newly created company led by a group of former AFFX execs, offered $16.10/share in cash, topping TMO's $14 offer that AFFX accepted on Jan. 8.

The $16.10 offer represents a 14.8% premium to AFFX's closing price yesterday.

Origin President Wei Zhou, a former senior VP at AFFX, also started up genomics company Centrillion Technology in 2009, and says Origin would have the option of combining with Centrillion after acquiring AFFX.

AFFX closed +14%, TMO ended +1.2%.

Subscribe for full text news in your inbox